Breast imaging has entered a transformative era, moving far beyond conventional two-dimensional mammography toward a suite of advanced, multimodal technologies designed to enhance detection, characterization, and patient comfort. This presentation will provide an overview of recent and emerging innovations in breast imaging, focusing on how technological advancements are reshaping the landscape of breast cancer diagnosis and management.

Magnetic resonance imaging (MRI) continues to play a critical role in high-risk screening and treatment planning, with novel contrast agents and abbreviated protocols broadening its accessibility.

A major highlight of this talk will be the introduction of Dedicated Breast Computed Tomography (DBCT), an emerging three-dimensional imaging modality that enables true volumetric visualization of breast tissue without compression. DBCT offers improved lesion conspicuity, enhanced patient comfort, and the potential for accurate quantitative assessment, marking a significant leap forward in breast imaging technology.

In addition, the presentation will explore the integration of artificial intelligence (AI) and radiomics into clinical practice—tools that promise to optimize image interpretation, standardize reporting, and enable personalized screening strategies. Together, these innovations are driving a paradigm shift from detection toward precision imaging and early intervention.

Ultimately, this session aims to provide an insightful overview of how the convergence of advanced imaging modalities, patient-centered design, and data-driven tools is shaping the future of breast imaging and improving outcomes for women.